Hims and Hers (HIMS) PT Raised to $61 at Needham

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Hims and Hers (HIMS) PT Raised to $61 at Needham

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

February 24, 2025 4:05 PM EST

Revenue of $1.5 billion, up 69% year-over-year in 2024

Net income of $126 million; Adjusted EBITDA of $177 million in 2024

Subscribers grew to 2.2 million, up 45% year-over-year in 2024

Provides Q1 and full year 2025 guidance, with full year 2025 revenue in the range of $2.3 billion to $2.4 billion and Adjusted EBITDA in the range of $270 million to $320 million

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today announced financial results for... More

Hims & Hers Acquires US-based Peptide Facility

February 21, 2025 9:00 AM EST

The acquisition will strengthen the long-term durability of the companys domestic supply chain, helping to ensure Americans can consistently access personalized medications

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc., the leading health and wellness platform, today announced an acquisition that will further verticalize the companys long-term ability to deliver personalized medications. The company has acquired a US-based peptide facility based in California. The acquisition will enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment... More